Fuller & Thaler Asset Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $2.52M | Sell |
|
|||||
|
2018
Q1 | $2.33M | Sell |
|
|||||
|
2017
Q4 | $2.01M | Sell |
|
|||||
|
2017
Q3 | $3.27M | Sell |
|
|||||
|
2017
Q2 | $3.03M | Sell |
|
|||||
|
2017
Q1 | $4.23M | Hold |
|
|||||
|
2016
Q4 | $3.87M | Hold |
|
|||||
|
2016
Q3 | $2.84M | Sell |
|
|||||
|
2016
Q2 | $1.95M | Buy |
|
|||||
|
2016
Q1 | $2.01M | Sell |
|
|||||
|
2015
Q4 | $3.73M | Buy |
|
|||||
|
2015
Q3 | $3.31M | Buy |
|
|||||
|
2015
Q2 | $4.31M | Buy |
|
|||||
|
2015
Q1 | $3.39M | Sell |
|
|||||
|
2014
Q4 | $4.29M | Buy |
|
|||||
|
2014
Q3 | $2.9M | Hold |
|
|||||
|
2014
Q2 | $2.41M | Buy |
|
|||||
|
2014
Q1 | $2.07M | Buy |
|